ATN1
Basic information
Region (hg38): 12:6924463-6942321
Previous symbols: [ "D12S755E", "DRPLA" ]
Links
Phenotypes
GenCC
Source:
- congenital hypotonia, epilepsy, developmental delay, and digital anomalies (Moderate), mode of inheritance: AD
- congenital hypotonia, epilepsy, developmental delay, and digital anomalies (Moderate), mode of inheritance: AD
- dentatorubral-pallidoluysian atrophy (Supportive), mode of inheritance: AD
- dentatorubral-pallidoluysian atrophy (Strong), mode of inheritance: AD
- congenital hypotonia, epilepsy, developmental delay, and digital anomalies (Strong), mode of inheritance: AD
- congenital hypotonia, epilepsy, developmental delay, and digital anomalies (Strong), mode of inheritance: AD
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Congenital hypotonia, epilepsy, developmental delay, and digital anomalies; Dentatorubro-pallidoluysian atrophy | AD | Cardiovascular | Individuals have been described with congenital heart anomalies, and awareness may enable early diagnosis and management | Cardiovascular; Craniofacial; Gastrointestinal; Musculoskeletal; Neurologic | 6808417; 2742549; 7951323; 8136840; 8041369; 7477999; 8644735; 9568927; 11160976; 15948186; 30827498 |
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn_genetic_diseases (189 variants)
- not_provided (124 variants)
- not_specified (33 variants)
- Congenital_hypotonia,_epilepsy,_developmental_delay,_and_digital_anomalies (31 variants)
- ATN1-related_disorder (26 variants)
- Dentatorubral-pallidoluysian_atrophy (6 variants)
- Congenital_ATN1_related_disorder (4 variants)
- See_cases (3 variants)
- X-linked_hydrocephalus_syndrome (1 variants)
- Intellectual_disability (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ATN1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000001940.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 35 | 4 | 41 | ||
| missense | 3 | 5 | 216 | 31 | 5 | 260 |
| nonsense | 3 | 3 | ||||
| start loss | 0 | |||||
| frameshift | 14 | 1 | 15 | |||
| splice donor/acceptor (+/-2bp) | 5 | 5 | ||||
| Total | 3 | 5 | 240 | 66 | 10 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| ATN1 | protein_coding | protein_coding | ENST00000356654 | 9 | 17859 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 125722 | 1 | 25 | 125748 | 0.000103 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 1.76 | 567 | 698 | 0.812 | 0.0000401 | 7471 |
| Missense in Polyphen | 305 | 400.34 | 0.76186 | 4425 | ||
| Synonymous | 1.25 | 273 | 300 | 0.909 | 0.0000178 | 2713 |
| Loss of Function | 5.42 | 3 | 40.0 | 0.0750 | 0.00000247 | 395 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.0000911 | 0.0000905 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.00160 | 0.000816 |
| Finnish | 0.0000974 | 0.0000924 |
| European (Non-Finnish) | 0.0000717 | 0.0000615 |
| Middle Eastern | 0.00160 | 0.000816 |
| South Asian | 0.00 | 0.00 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Transcriptional corepressor. Recruits NR2E1 to repress transcription. Promotes vascular smooth cell (VSMC) migration and orientation (By similarity). Corepressor of MTG8 transcriptional repression. Has some intrinsic repression activity which is independent of the number of poly-Gln (polyQ) repeats. {ECO:0000250, ECO:0000269|PubMed:10085113, ECO:0000269|PubMed:10973986}.;
- Disease
- DISEASE: Dentatorubral-pallidoluysian atrophy (DRPLA) [MIM:125370]: Autosomal dominant neurodegenerative disorder characterized by a loss of neurons in the dentate nucleus, rubrum, glogus pallidus and Luys'body. Clinical features are myoclonus epilepsy, dementia, and cerebellar ataxia. Onset of the disease occurs usually in the second decade of life and death in the fourth. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Signal Transduction;Regulation of PTEN gene transcription;PTEN Regulation;PIP3 activates AKT signaling;Intracellular signaling by second messengers
(Consensus)
Recessive Scores
- pRec
- 0.523
Intolerance Scores
- loftool
- 0.566
- rvis_EVS
- -0.95
- rvis_percentile_EVS
- 9.34
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.453
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;central nervous system development;neuron apoptotic process
- Cellular component
- nucleus;nucleoplasm;cytoplasm;nuclear matrix;cell junction;perinuclear region of cytoplasm
- Molecular function
- RNA polymerase II transcription factor binding;DNA binding;transcription corepressor activity;protein binding;protein domain specific binding